GlassScriptPhysician profile
Douglas A Smith
NPI 1841433844
$5,622.45
in general payments reported to CMS, 2019-2025
9 companies · $615 in 2025
The $615 reported for 2025 was less than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $499 · 2020: $142 · 2021: $475 · 2022: $987 · 2023: $1,296 · 2024: $1,608 · 2025: $615.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,778 · Food and Beverage: $1,505 · Travel and Lodging: $237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,777.50 |
| Food and Beverage | $1,505.27 |
| Travel and Lodging | $236.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $2,605.50 | 2019-2025 | Va-Lcp, Na, Tfn-Advance |
| Medical Device Business Services, INC. | $1,777.50 | 2023-2024 | |
| Globus Medical, INC. | $619.17 | 2022-2023 | Clavicular Fracture Fixation, Distal Femur Plate System |
| Stryker Corporation | $182.81 | 2019-2025 | Pelvis II, Variax |
| Integra Lifesciences Corporation | $132.43 | 2022 | |
| Smith+Nephew, INC. | $119.51 | 2019 | |
| Pylant Medical | $85.10 | 2024-2025 | |
| Innovation Technologies INC | $62.68 | 2023 | Irrisept |
| Biocomposites INC | $37.75 | 2023 | Stimulan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.